Efficacy and safety of adjunctive pharmacologic treatments for alcohol addiction in patients with schizophrenia and bipolar disorder

被引：0
|
作者：
Noehles, V. B. [1 ]
Correll, C. U. [1 ]
Roldan, A. [2 ]
Galling, B. [1 ]
机构：
[1] Charite, Dept Child & Adolescent Psychiat, Berlin, Germany
[2] Hosp Santa Creu & Sant Pau, Dept Psychiat, Inst Invest Biomed St Pau IIB ST PAU, Barcelona, Spain
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2019年 / 29卷
关键词：
SUBSTANCE USE DISORDERS;
D O I：
10.1016/j.euroneuro.2018.11.725
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.709
引用
收藏
页码：S484 / S485
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of oxcarbazepine in bipolar disorder
    Mazza, Marianna
    Bria, Pietro
    Mazza, Salvatore
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2007, 52 (04): : 272 - 272
  • [22] Polygenic risk scores for schizophrenia and bipolar disorder associate with addiction
    Reginsson, Gunnar W.
    Ingason, Andres
    Euesden, Jack
    Bjornsdottir, Gyda
    Olafsson, Sigurgeir
    Sigurdsson, Engilbert
    Oskarsson, Hogni
    Tyrfingsson, Thorarinn
    Runarsdottir, Valgerdur
    Hansdottir, Ingunn
    Steinberg, Stacy
    Stefansson, Hreinn
    Gudbjartsson, Daniel F.
    Thorgeirsson, Thorgeir E.
    Stefansson, Kari
    ADDICTION BIOLOGY, 2018, 23 (01) : 485 - 492
  • [23] The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia
    Ashton, Melanie M.
    Dean, Olivia M.
    Walker, Adam J.
    Bortolasci, Chiara C.
    Ng, Chee H.
    Hopwood, Malcolm
    Harvey, Brian H.
    Moller, Marisa
    McGrath, John J.
    Marx, Wolfgang
    Turner, Alyna
    Dodd, Seetal
    Scott, James G.
    Khoo, Jon-Paul
    Walder, Ken
    Sarris, Jerome
    Berk, Michael
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [24] Efficacy and safety of armodafinil as an adjunctive therapy for the treatment of a major depressive episode associated with bipolar I disorder
    Frye, M. A.
    Ketter, T. A.
    Yang, R.
    BIPOLAR DISORDERS, 2013, 15 : 126 - 127
  • [25] EFFICACY AND TOLERABILITY OF ADJUNCTIVE ARMODAFINIL IN PATIENTS WITH SCHIZOPHRENIA
    Kane, John M.
    D'Souza, D. C.
    Patkar, A. A.
    Youakim, J. M.
    Tiller, J.
    Yang, R.
    Keefe, R. S.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 356 - 357
  • [26] Efficacy and Safety of Adjunctive Aripiprazole LAI or Paliperidone LAI for the Management of Patients Suffering from Bipolar I Disorder with Comorbid Obsessive-Compulsive Disorder
    Martiadis, Vassilis
    Pessina, Enrico
    Raffone, Fabiola
    Martini, Azzurra
    Di Vincenzo, Matteo
    Della Rocca, Bianca
    De Berardis, Domenico
    Cattaneo, Carlo Ignazio
    Sampogna, Gaia
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [27] Efficacy and safety of iclepertin (BI 425809) with adjunctive computerized cognitive training in patients with schizophrenia
    Harvey, Philip D.
    Mcdonald, Sean
    Fu, Eric
    Reuteman-Fowler, Corey
    SCHIZOPHRENIA RESEARCH-COGNITION, 2025, 40
  • [28] Individualizing Treatment for Patients With Bipolar Disorder: Optimizing Efficacy, Safety, and Tolerability
    Correll, Christoph U.
    ANNALS OF CLINICAL PSYCHIATRY, 2011, : 49 - 81
  • [29] Pharmacokinetics, Safety, and Tolerability of Cariprazine in Pediatric Patients with Bipolar I Disorder or Schizophrenia
    Riccobene, Todd
    Riesenberg, Robert
    Yeung, Paul P.
    Earley, Willie R.
    Hankinson, Arlene L.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2022, 32 (08) : 434 - 443
  • [30] Safety and tolerability of emerging pharmacological treatments for bipolar disorder
    Dunner, DL
    BIPOLAR DISORDERS, 2005, 7 (04) : 307 - 325
12345